Nightingale by Health Care Originals® Raises $2M to Revolutionize Respiratory Care for 50 Million Americans

Nightingale by Health Care Originals® is thrilled to announce a remarkable funding milestone, having recently raised $2,000,000 to further advance its pioneering work in virtual respiratory care. Nearly 50 million Americans face the daily challenges of Asthma, COPD, or both, and our mission is to transform how these chronic conditions are managed by offering the first complete virtual respiratory care platform. This ground-breaking system integrates innovative telehealth technology and personalized treatment plans to empower patients, improve outcomes, and enhance quality of life. The substantial capital injection will be strategically deployed to refine our digital platform, expand its reach into underserved communities, and develop cutting-edge features that support proactive disease management. By leveraging the latest advancements in data analytics and remote monitoring, Nightingale is committed to providing a seamless, comprehensive, and compassionate care experience that adapts to the unique needs of each patient. The funds will also boost our research efforts, ensuring that our platform remains at the forefront of respiratory care innovation and continues to deliver meaningful insights to healthcare providers nationwide. This investment is a powerful endorsement of our vision to revolutionize respiratory healthcare, making it more accessible, efficient, and patient-centric. As we embark on this exciting next chapter, our commitment to transforming the lives of those with respiratory conditions remains stronger than ever. With the support of our investors and the dedication of our team, Nightingale is poised to set new standards in digital healthcare and create lasting improvements in the management and treatment of Asthma and COPD.